Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay

Lancet

Volumn 358, Issue 9277, 2001, Pages 171-180

  Wadsworth, J D F ^a   Joiner, S ^a   Hill, A F ^a   Campbell, T A ^a   Desbruslais, M ^a   Luthert, P J ^b   Collinge, J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; PRION PROTEIN; PROTEINASE K; SODIUM PHOSPHOTUNGSTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BRAIN HOMOGENATE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LYMPH NODE; OPTIC NERVE; PRECIPITATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SPIKE; SPLEEN; TISSUE DISTRIBUTION; TONSIL; WESTERN BLOTTING;

EID: 0035928432     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05403-4     Document Type: Article

References (47)

1. Self replication and scrapie
2. Novel proteinaceous infectious particles cause scrapie
3. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent
4. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
5. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
6. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity
7. Sc molecules with different conformations
8. Strain-specific prion-protein conformation determined by metal ions
9. The same prion strain causes vCJD and BSE
10. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
11. Variant Creutzfeldt-Jakob disease
12. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
13. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
14. Retrospective study of prion-protein accumulation in tonsil and appendix tissues
15. Creutzfeldt-Jakob disease and blood transfusion
16. A crucial role for B cells in neuroinvasive scrapie
17. Blood transfusion risk: Protecting against the unknown
18. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery
19. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case-control study
20. Infectivity of scrapie prions bound to a stainless steel surface
21. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease
22. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein
23. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): An update
24. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE)
25. Transmission of bovine spongiform encephalopathy and scrapie to mice: Strain variation and the species barrier
26. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
27. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases)
28. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
29. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein
30. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
31. Pathogenesis of experimental scrapie
32. Mice devoid of PrP are resistant to scrapie
33. Species barrier independent prion replication in apparently resistant species
34. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
35. Predicted vCJD mortality in Great Britain
36. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly
37. Infectivity in extraneural tissues following intraocular scrapie infection
38. Measurement of the scrapie agent using an incubation time interval assay
39. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice
40. Transmission of BSE by blood transfusion in sheep
41. Fatal familial insomnia: A second kindred with mutation of prion protein gene at codon 178
42. Transmission of fatal familial insomnia to laboratory animals
43. Spontaneous neurodegeneration in transgenic mice with mutant prion protein
44. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
45. Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease
46. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice